What is it about?
The 15 years experience of developing influenza vaccine in Vero cell line is described
Featured Image
Why is it important?
The paper explains the reasons why Vero-produced vaccines did not work in clinical trial
Perspectives
Read the Original
This page is a summary of: Influenza vaccines manufacturing in continuous cell lines: problems and solutions, Microbiology Independent Research Journal (MIR Journal), January 2017, Doctrina, Ltd.,
DOI: 10.18527/2500-2236-2017-4-1-1-9.
You can read the full text:
Resources
Contributors
The following have contributed to this page